Anica Dricu

Bucharest, B 050474, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Obstacles and Trials in Treating Primary Brain Tumors.

Obstacles and Trials in Treating Primary Brain Tumors.

Journal: International journal of molecular sciences

Published: June 30, 2026

Promoter Methylation-Expression Coupling of Gliogenesis Genes in IDH-Wildtype Glioblastoma: Longitudinal Analysis and Prognostic Value.

Promoter Methylation-Expression Coupling of Gliogenesis Genes in IDH-Wildtype Glioblastoma: Longitudinal Analysis and Prognostic Value.

Journal: International journal of molecular sciences

Published: December 09, 2025

Redundancy in Growth Factor Receptor Signaling in Adult Astrocytoma Resistance to Small-Molecule Tyrosine Kinase Inhibitors.

Redundancy in Growth Factor Receptor Signaling in Adult Astrocytoma Resistance to Small-Molecule Tyrosine Kinase Inhibitors.

Journal: International journal of molecular sciences

Published: November 28, 2025

The PitNET Puzzle: From Zero to Linking Molecular Behavior with Neurosurgical Aspects.

The PitNET Puzzle: From Zero to Linking Molecular Behavior with Neurosurgical Aspects.

Journal: Medicina (Kaunas, Lithuania)

Published: July 31, 2025

Improving the Response of High-Grade Glioma (HGG) Cells to Temozolomide Treatment Through Combination With Imatinib.

Improving the Response of High-Grade Glioma (HGG) Cells to Temozolomide Treatment Through Combination With Imatinib.

Journal: Cureus

Published: July 15, 2025

Current Research Trends in Glioblastoma: Focus on Receptor Tyrosine Kinases.

Current Research Trends in Glioblastoma: Focus on Receptor Tyrosine Kinases.

Journal: International journal of molecular sciences

Published: January 29, 2025

A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy.

A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy.

Journal: International journal of molecular sciences

Published: January 09, 2025

Evaluation of the Demographics, Clinical Laboratory Parameters, and Outcomes of Hospitalized Oncological Versus Non-oncological COVID-19 Patients.

Evaluation of the Demographics, Clinical Laboratory Parameters, and Outcomes of Hospitalized Oncological Versus Non-oncological COVID-19 Patients.

Journal: Cureus

Published: November 08, 2024

Evaluation of Single and Combined Temozolomide and Doxorubicin Treatment Responses in Low- and High-Grade Glioma In Vitro.

Evaluation of Single and Combined Temozolomide and Doxorubicin Treatment Responses in Low- and High-Grade Glioma In Vitro.

Journal: Cureus

Published: August 14, 2024

Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.

Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.

Journal: International journal of molecular sciences

Published: August 11, 2024

Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance.

Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance.

Journal: Current issues in molecular biology

Published: August 01, 2024

Combined Statistical Analysis of Glioblastoma Outcomes-A Neurosurgical Single-Institution Retrospective Study.

Combined Statistical Analysis of Glioblastoma Outcomes-A Neurosurgical Single-Institution Retrospective Study.

Journal: Medicina (Kaunas, Lithuania)

Published: June 24, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026